Brinckerhoff to Present on Medical Treatment and Diagnostic Methods in Canada and the U.S.
15 April 2016
The web conference, entitled, “Medical Treatment and Diagnostic Methods in Canada and the US: What are the Courts and Patent Offices Saying?” will address:
- Recent case law relating to the patentability of methods of medical treatment and diagnostic methods in the U.S. and Canada;
- The Canadian Intellectual Property Office’s (CIPO) Revised Examination Practice Respecting Medical Uses and Examination Practice Respecting Medical Diagnostic Methods; and
- Tips and tricks in drafting medical treatment and diagnostic method claims, and responding to objections.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.